PAMINE FORTE Drug Patent Profile
✉ Email this page to a colleague
When do Pamine Forte patents expire, and when can generic versions of Pamine Forte launch?
Pamine Forte is a drug marketed by Fougera and is included in one NDA.
The generic ingredient in PAMINE FORTE is methscopolamine bromide. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pamine Forte
A generic version of PAMINE FORTE was approved as methscopolamine bromide by BRECKENRIDGE PHARM on December 6th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PAMINE FORTE?
- What are the global sales for PAMINE FORTE?
- What is Average Wholesale Price for PAMINE FORTE?
Summary for PAMINE FORTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 56 |
| Patent Applications: | 891 |
| DailyMed Link: | PAMINE FORTE at DailyMed |
US Patents and Regulatory Information for PAMINE FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera | PAMINE FORTE | methscopolamine bromide | TABLET;ORAL | 008848-002 | Mar 25, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
